{"id":"https://openalex.org/W4297229014","doi":"https://doi.org/10.3389/fonc.2022.900082","title":"Circulating metabolites associated with tumor hypoxia and early response to treatment in bevacizumab-refractory glioblastoma after combined bevacizumab and evofosfamide","display_name":"Circulating metabolites associated with tumor hypoxia and early response to treatment in bevacizumab-refractory glioblastoma after combined bevacizumab and evofosfamide","publication_year":2022,"publication_date":"2022-09-26","ids":{"openalex":"https://openalex.org/W4297229014","doi":"https://doi.org/10.3389/fonc.2022.900082","pmid":"https://pubmed.ncbi.nlm.nih.gov/36226069","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9549210"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2022.900082","doi":"https://doi.org/10.3389/fonc.2022.900082","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.900082","pdf_url":null,"source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fonc.2022.900082","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091298013","display_name":"Alessia Lodi","orcid":"https://orcid.org/0000-0002-2104-5713","observed_orcids":["https://orcid.org/0000-0002-2104-5713"]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Alessia Lodi","raw_affiliation_strings":["Dell Pediatric Research Institute, Dell Medical School, The University of Texas at Austin, Austin, TX, United States","Department of Nutritional Sciences, The University of Texas at Austin, Austin, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dell Pediatric Research Institute, Dell Medical School, The University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"Department of Nutritional Sciences, The University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Renu Pandey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Renu Pandey","raw_affiliation_strings":["Dell Pediatric Research Institute, Dell Medical School, The University of Texas at Austin, Austin, TX, United States","Department of Nutritional Sciences, The University of Texas at Austin, Austin, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dell Pediatric Research Institute, Dell Medical School, The University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"Department of Nutritional Sciences, The University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091342349","display_name":"Jennifer Chiou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Chiou","raw_affiliation_strings":["Dell Pediatric Research Institute, Dell Medical School, The University of Texas at Austin, Austin, TX, United States","Department of Nutritional Sciences, The University of Texas at Austin, Austin, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dell Pediatric Research Institute, Dell Medical School, The University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"Department of Nutritional Sciences, The University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112004335","display_name":"Ayon Bhattacharya","orcid":"https://orcid.org/0000-0002-9111-5705","observed_orcids":["https://orcid.org/0000-0002-9111-5705"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]},{"id":"https://openalex.org/I4390039360","display_name":"Mays Cancer Center at UT Health San Antonio","ror":"https://ror.org/04aysmc18","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165951966","https://openalex.org/I4390039360","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ayon Bhattacharya","raw_affiliation_strings":["Mays Cancer Center, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mays Cancer Center, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States","institution_ids":["https://openalex.org/I165951966","https://openalex.org/I4390039360"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032782538","display_name":"Shi\u2010Liang Huang","orcid":"https://orcid.org/0000-0003-0878-5503","observed_orcids":["https://orcid.org/0000-0003-0878-5503"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]},{"id":"https://openalex.org/I4390039360","display_name":"Mays Cancer Center at UT Health San Antonio","ror":"https://ror.org/04aysmc18","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165951966","https://openalex.org/I4390039360","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shiliang Huang","raw_affiliation_strings":["Mays Cancer Center, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mays Cancer Center, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States","institution_ids":["https://openalex.org/I165951966","https://openalex.org/I4390039360"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101833452","display_name":"Xingxin Pan","orcid":"https://orcid.org/0000-0002-4429-4878","observed_orcids":["https://orcid.org/0000-0002-4429-4878"]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xingxin Pan","raw_affiliation_strings":["Department of Oncology, Dell Medical School, Livestrong Cancer Institutes, The University of Texas at Austin, Austin, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Dell Medical School, Livestrong Cancer Institutes, The University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000344944","display_name":"Brandon Burgman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brandon Burgman","raw_affiliation_strings":["Department of Oncology, Dell Medical School, Livestrong Cancer Institutes, The University of Texas at Austin, Austin, TX, United States","Institute for Cellular and Molecular Biology (ICMB), College of Natural Sciences, The University of Texas at Austin, Austin, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Dell Medical School, Livestrong Cancer Institutes, The University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"Institute for Cellular and Molecular Biology (ICMB), College of Natural Sciences, The University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063496035","display_name":"S. Stephen Yi","orcid":"https://orcid.org/0000-0003-0047-8103","observed_orcids":["https://orcid.org/0000-0003-0047-8103"]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Stephen Yi","raw_affiliation_strings":["Department of Biomedical Engineering, Cockrell School of Engineering, The University of Texas at Austin, Austin, TX, United States","Department of Oncology, Dell Medical School, Livestrong Cancer Institutes, The University of Texas at Austin, Austin, TX, United States","Institute for Cellular and Molecular Biology (ICMB), College of Natural Sciences, The University of Texas at Austin, Austin, TX, United States","Oden Institute for Computational Engineering and Sciences (ICES), The University of Texas at Austin, Austin, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, Cockrell School of Engineering, The University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"Department of Oncology, Dell Medical School, Livestrong Cancer Institutes, The University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"Institute for Cellular and Molecular Biology (ICMB), College of Natural Sciences, The University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"Oden Institute for Computational Engineering and Sciences (ICES), The University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018582351","display_name":"Stefano Tiziani","orcid":"https://orcid.org/0000-0002-7230-0307","observed_orcids":["https://orcid.org/0000-0002-7230-0307","https://orcid.org/0000-0003-1892-2495"]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stefano Tiziani","raw_affiliation_strings":["Dell Pediatric Research Institute, Dell Medical School, The University of Texas at Austin, Austin, TX, United States","Department of Nutritional Sciences, The University of Texas at Austin, Austin, TX, United States","Department of Oncology, Dell Medical School, Livestrong Cancer Institutes, The University of Texas at Austin, Austin, TX, United States","Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, TX, United States","Institute for Cellular and Molecular Biology (ICMB), College of Natural Sciences, The University of Texas at Austin, Austin, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dell Pediatric Research Institute, Dell Medical School, The University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"Department of Nutritional Sciences, The University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"Department of Oncology, Dell Medical School, Livestrong Cancer Institutes, The University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"Institute for Cellular and Molecular Biology (ICMB), College of Natural Sciences, The University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083922162","display_name":"Andrew Jacob Brenner","orcid":"https://orcid.org/0000-0002-3985-253X","observed_orcids":["https://orcid.org/0000-0002-3985-253X"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]},{"id":"https://openalex.org/I4390039360","display_name":"Mays Cancer Center at UT Health San Antonio","ror":"https://ror.org/04aysmc18","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165951966","https://openalex.org/I4390039360","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Andrew J. Brenner","raw_affiliation_strings":["Mays Cancer Center, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mays Cancer Center, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States","institution_ids":["https://openalex.org/I165951966","https://openalex.org/I4390039360"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5083922162","https://openalex.org/A5091298013"],"corresponding_institution_ids":["https://openalex.org/I165951966","https://openalex.org/I4390039360","https://openalex.org/I86519309"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":1.2428,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.78497409,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":98},"biblio":{"volume":"12","issue":null,"first_page":"900082","last_page":"900082"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.8637999892234802,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.8637999892234802,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.10159999877214432,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10836","display_name":"Metabolomics and Mass Spectrometry Studies","score":0.023099999874830246,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9739999771118164},{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.9639999866485596},{"id":"https://openalex.org/keywords/circulating-metabolites","display_name":"circulating metabolites","score":0.8989999890327454},{"id":"https://openalex.org/keywords/metabolic-biomarkers","display_name":"metabolic biomarkers","score":0.8299999833106995},{"id":"https://openalex.org/keywords/bevacizumab-resistance","display_name":"bevacizumab resistance","score":0.9079999923706055},{"id":"https://openalex.org/keywords/evofosfamide","display_name":"evofosfamide","score":0.996999979019165},{"id":"https://openalex.org/keywords/hypoxia-activated-prodrug","display_name":"hypoxia-activated prodrug","score":0.9419999718666077},{"id":"https://openalex.org/keywords/recurrent-glioblastoma","display_name":"recurrent glioblastoma","score":0.9179999828338623},{"id":"https://openalex.org/keywords/gaba","display_name":"GABA","score":0.8420000076293945},{"id":"https://openalex.org/keywords/glutamate","display_name":"glutamate","score":0.8059999942779541},{"id":"https://openalex.org/keywords/serine-synthesis-pathway","display_name":"serine synthesis pathway","score":0.8880000114440918},{"id":"https://openalex.org/keywords/lactic-acid","display_name":"lactic acid","score":0.8289999961853027},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.5889999866485596}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8383139371871948},{"id":"https://openalex.org/C7836513","wikidata":"https://www.wikidata.org/wiki/Q1641506","display_name":"Hypoxia (environmental)","level":3,"score":0.67513108253479},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5907169580459595},{"id":"https://openalex.org/C2779081379","wikidata":"https://www.wikidata.org/wiki/Q7852677","display_name":"Tumor hypoxia","level":3,"score":0.568227231502533},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4809812307357788},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.4784669578075409},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.443185955286026},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4333343207836151},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39877796173095703},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3944430947303772},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.22183743119239807},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.21607714891433716},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.16678526997566223},{"id":"https://openalex.org/C540031477","wikidata":"https://www.wikidata.org/wiki/Q629","display_name":"Oxygen","level":2,"score":0.07080963253974915},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2022.900082","doi":"https://doi.org/10.3389/fonc.2022.900082","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.900082","pdf_url":null,"source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9549210","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9549210","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmid:36226069","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36226069","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:8d649ef526fa419aa6476b5269c3dcc0","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/8d649ef526fa419aa6476b5269c3dcc0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 12 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2022.900082","doi":"https://doi.org/10.3389/fonc.2022.900082","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.900082","pdf_url":null,"source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1809273039","display_name":"Network-based Framework to Decode Novel \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00c2\u0080\u00c3\u0082\u00c2\u0098Gain-of-Function\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00c2\u0080\u00c3\u0082\u00c2\u0099 Mutations and their Mechanistic Roles in General Human Diseases","funder_award_id":"R35GM133658","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332163","display_name":"U.S. Food and Drug Administration","ror":"https://ror.org/034xvzb47"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W1495358463","https://openalex.org/W1900467627","https://openalex.org/W1916910865","https://openalex.org/W1948988765","https://openalex.org/W1978321327","https://openalex.org/W1987752687","https://openalex.org/W1992521533","https://openalex.org/W1993131067","https://openalex.org/W1999886232","https://openalex.org/W2009447162","https://openalex.org/W2014125735","https://openalex.org/W2030763674","https://openalex.org/W2064144156","https://openalex.org/W2077897916","https://openalex.org/W2080452140","https://openalex.org/W2081772234","https://openalex.org/W2103044444","https://openalex.org/W2121906940","https://openalex.org/W2148977460","https://openalex.org/W2162935096","https://openalex.org/W2173466127","https://openalex.org/W2205491921","https://openalex.org/W2345635417","https://openalex.org/W2402062284","https://openalex.org/W2418570604","https://openalex.org/W2566090297","https://openalex.org/W2581756437","https://openalex.org/W2591697035","https://openalex.org/W2592158987","https://openalex.org/W2593344067","https://openalex.org/W2602388182","https://openalex.org/W2616936258","https://openalex.org/W2624776556","https://openalex.org/W2626249188","https://openalex.org/W2770385913","https://openalex.org/W2792172810","https://openalex.org/W2803472528","https://openalex.org/W2804225817","https://openalex.org/W2898529188","https://openalex.org/W2990399106","https://openalex.org/W3001327566","https://openalex.org/W3001549748","https://openalex.org/W3004208898","https://openalex.org/W3004999773","https://openalex.org/W3010876716","https://openalex.org/W3027643845","https://openalex.org/W3126073266","https://openalex.org/W3151638254","https://openalex.org/W3152397551","https://openalex.org/W3161496832","https://openalex.org/W4211220688"],"related_works":["https://openalex.org/W3152397551","https://openalex.org/W2163038498","https://openalex.org/W2669032617","https://openalex.org/W2013996093","https://openalex.org/W3100888824","https://openalex.org/W4310766038","https://openalex.org/W2792172810","https://openalex.org/W2767578686","https://openalex.org/W1996868519","https://openalex.org/W2042305857"],"abstract_inverted_index":{"Glioblastomas":[0],"(GBM)":[1],"are":[2],"the":[3,15,28,46,169,232,239],"most":[4],"common":[5],"and":[6,27,48,72,112,139,150,187,237,244],"aggressive":[7],"form":[8,158],"of":[9,64,95,168,206,234,241],"primary":[10],"malignant":[11],"brain":[12],"tumor":[13,47,96,165,184,235],"in":[14,45,57,69,98,130,141,199,219,247],"adult":[16],"population,":[17],"and,":[18],"despite":[19],"modern":[20],"therapies,":[21],"patients":[22],"often":[23],"develop":[24],"recurrent":[25,142],"disease,":[26],"disease":[29],"remains":[30],"incurable":[31],"with":[32,136,164,183],"median":[33],"survival":[34],"below":[35],"2":[36],"years.":[37],"Resistance":[38],"to":[39,108,121,125,176,201],"bevacizumab":[40,80,138,145,243,250],"is":[41,50,174],"driven":[42],"by":[43,87,179,196],"hypoxia":[44,97,185,203,236],"evofosfamide":[49,140,245],"a":[51,58,102,202],"hypoxia-activated":[52],"prodrug,":[53],"which":[54,173],"we":[55,100,127,223],"tested":[56],"phase":[59],"2,":[60],"dual":[61],"center":[62],"(University":[63],"Texas":[65],"Health":[66],"Science":[67],"Center":[68],"San":[70],"Antonio":[71],"Dana":[73],"Farber":[74],"Cancer":[75],"Institute)":[76],"clinical":[77],"trial":[78],"after":[79,144],"failure.":[81,146,251],"Tumor":[82],"hypoxic":[83],"volume":[84],"was":[85,194],"quantified":[86],"18F-misonidazole":[88],"PET.":[89],"To":[90],"identify":[91],"circulating":[92,131],"metabolic":[93,227],"biomarkers":[94,228],"patients,":[99],"used":[101],"high-resolution":[103],"liquid":[104],"chromatography-mass":[105],"spectrometry-based":[106],"approach":[107],"profile":[109],"blood":[110],"metabolites":[111],"their":[113],"specific":[114],"enantiomeric":[115,157],"forms":[116],"using":[117],"untargeted":[118],"approaches.":[119],"Moreover,":[120,189],"evaluate":[122,231],"early":[123],"response":[124,200],"treatment,":[126,191,197],"characterized":[128],"changes":[129],"metabolite":[132],"levels":[133],"during":[134],"treatment":[135,246],"combined":[137,242],"GBM":[143,248],"Gamma":[147],"aminobutyric":[148],"acid,":[149],"glutamic":[151],"acid":[152,160,193],"as":[153,155],"well":[154],"its":[156],"D-glutamic":[159],"all":[161],"inversely":[162],"correlated":[163,182],"hypoxia.":[166],"Intermediates":[167],"serine":[170],"synthesis":[171],"pathway,":[172],"known":[175],"be":[177],"modulated":[178,195],"hypoxia,":[180],"also":[181],"(phosphoserine":[186],"serine).":[188],"following":[190,249],"lactic":[192],"likely":[198],"mediated":[204],"modulation":[205],"oxidative":[207],"vs":[208],"glycolytic":[209],"metabolism.":[210],"In":[211],"summary,":[212],"although":[213],"our":[214],"results":[215],"require":[216],"further":[217],"validation":[218],"larger":[220],"patients'":[221],"cohorts,":[222],"have":[224],"identified":[225],"candidate":[226],"that":[229],"could":[230],"extent":[233],"predict":[238],"benefit":[240]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":2}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2022-09-28T00:00:00"}